Skip to main navigation Skip to search Skip to main content

Induced nitric oxide inhibits IL-6-induced Stat3 activation and type II acute phase mRNA expression

  • Raphael T. Villavicencio
  • , Shubing Liu
  • , Melina R. Kibbe
  • , Debra L. Williams
  • , Raymond W. Ganster
  • , Kevin F. Dyer
  • , David J. Tweardy
  • , Timothy R. Billiar
  • , Bruce R. Pitt*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Inducible nitric oxide synthase (iNOS) can be coexpressed with acute phase reactants in hepatocytes; however, it is unknown if NO can regulate the acute phase response. We tested the hypothesis that iNOS-derived nitric oxide (NO) attenuates the acute phase response by inhibiting IL-6-enhanced Stat3 DNA-binding activity and type II acute phase mRNA expression. iNOS was overexpressed in cultured rat hepatocytes via transduction with a replication defective adenovirus containing cDNA for human iNOS (AdiNOS), and Stat3 DNA-binding activity was determined by electrophoretic mobility shift assay (EMSA). EMSAs demonstrated that AdiNOS inhibits IL-6-induced Stat3 activation and that this inhibition is reversible in the presence of the NOS inhibitor NG-monomethyl-L-arginine (L-NMA). The induction of β-fibrinogen mRNA by IL-6, a Stat3 dependent process, is attenuated in AdiNOS-transduced cells and partially reversed by L-NMA. Thus, iNOS overexpression suppresses IL-6-induced Stat3 activation and type II acute phase mRNA expression in cultured hepatocytes. This suppression may represent a mechanism by which NO down-regulates the acute phase response.

Original languageEnglish
Pages (from-to)441-445
Number of pages5
JournalShock
Volume13
Issue number6
DOIs
StatePublished - Jun 2000
Externally publishedYes

Keywords

  • Adenoviral vector
  • Hepatocytes
  • Inducible nitric oxide synthase
  • Interleukin 6
  • Stat3
  • β-fibrinogen

Fingerprint

Dive into the research topics of 'Induced nitric oxide inhibits IL-6-induced Stat3 activation and type II acute phase mRNA expression'. Together they form a unique fingerprint.

Cite this